Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
55 hedge funds and large institutions have $408M invested in Taro Pharmaceutical Industries Ltd. in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
86% more capital invested
Capital invested by funds: $219M → $408M (+$189M)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
17% more funds holding
Funds holding: 47 → 55 (+8)
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $208K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$7.91M |
| 2 |
PA
Perceptive Advisors
New York
|
+$4.91M |
| 3 |
Renaissance Technologies
New York
|
+$1.94M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.75M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$1.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$1.5M |
| 2 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$1.32M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$343K |
| 4 |
VCAM
Valentine Capital Asset Management
Danville,
California
|
-$336K |
| 5 |
TCM
Touradji Capital Management
Boca Raton,
Florida
|
-$327K |
TARO Hedge Fund Activity: Q4 2013 in Review
55 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2013, worth a combined $408M — up 86% from $219M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TARO positions and 3 closed out — a net gain of 8 holders — while 16 added to existing stakes and 20 trimmed.
The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $7.91M. The largest seller was D.E. Shaw & Co, cutting an estimated $1.5M.
- 55 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2013, up from 47 in Q3 2013.
- Funds reported $408M of Taro Pharmaceutical Industries Ltd. stock for Q4 2013, up 86% quarter-over-quarter.
- 11 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2013 and 3 closed out, a net change of +8 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2013 was Hotchkis & Wiley Capital Management, an estimated $7.91M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2013 was D.E. Shaw & Co, an estimated $1.5M sold.
Based on aggregated 13F filings for Q4 2013.